Key result
Bilateral striatal injection of 6-OHDA did not affect heart rate variability in female rats, independent of ovariectomy.
Why the study?
Autonomic dysfunction affects most patients with Parkinson disease, but data were lacking regarding autonomic cardiac function in females after 6-hydroxydopamine striatal injection.
Does 6-OHDA striatal injection affect heart rate variability in ovariectomized female rats?
Does 6-OHDA striatal injection affect heart rate variability in ovariectomized female rats?
In a female rat model of Parkinson's disease, 6-OHDA-induced lesions did not affect heart rate variability, suggesting a cardioprotective effect independent of ovarian hormones.
No effect of 6-OHDA on HRV in female rats, independent of ovariectomy; leaves open whether this PD model captures cardiac autonomic dysfunction.
OBJECTIVES: In addition to the classic motor symptoms of Parkinson's disease (PD), patients also present with non-motor symptoms, such as autonomic dysfunction, which is present in almost 90% of patients with PD, affecting the quality of life and mortality. Regarding sex differences in prevalence and presentation, there is increasing concern about how sex affects autonomic dysfunction. However, there are no previous data on autonomic cardiac function in females after 6-hydroxydopamine (6-OHDA) striatal injection. METHODS: Wistar female rats were ovariectomized. After 20 days, the animals received bilateral injections of 6-OHDA (total dose per animal: 48 µg) or a vehicle solution in the striatum. Thirty days after 6-OHDA injection, subcutaneous electrodes were implanted for electrocardiogram (ECG) recording. Ten days after electrode implantation, ECG signals were recorded. Analyses of heart rate variability (HRV) parameters were performed, and the 6-OHDA lesion was confirmed by analyzing the number of tyrosine hydroxylase-positive neurons in the substantia nigra pars compacta (SNpc). RESULTS: A high dose of 6-OHDA did not affect HRV of females, independent of ovariectomy. As expected, ovariectomy did not affect HRV or lesions in the SNpc after 6-OHDA injection. CONCLUSIONS: We suggest that females with 6-OHDA present with cardioprotection, independent of ovarian hormones, which could be related to female vagal predominance.
No takes yet. Share an insight, caveat, or question.
Rosa et al. (2021) studied Parkinson's disease model (autonomic dysfunction). 6-hydroxydopamine (6-OHDA) and ovariectomy vs. Vehicle solution was evaluated on Heart rate variability (HRV) parameters. Bilateral striatal injection of 6-OHDA did not affect heart rate variability in female rats, independent of ovariectomy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: